Home/Filings/4/0001104659-22-079983
4//SEC Filing

ALBAN CARLOS 4

Accession 0001104659-22-079983

CIK 0001773427other

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 6:07 AM ET

Size

7.8 KB

Accession

0001104659-22-079983

Insider Transaction Report

Form 4
Period: 2022-07-14
ALBAN CARLOS
Director
Transactions
  • Award

    Common Stock

    2022-07-14+10,05810,058 total
  • Award

    Stock Option (Right to Buy)

    2022-07-14+30,16030,160 total
    Exercise: $28.93Exp: 2032-07-14Common Stock (30,160 underlying)
Footnotes (3)
  • [F1]This transaction represents a grant of restricted stock units ("RSUs") pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for initial equity grants to the Issuer's non-employee directors on the date of the Reporting Person's commencement of service to the Issuer. The RSUs shall vest in three (3) equal annual installments following July 14, 2022, subject to continued service to the Issuer by the Reporting Person.
  • [F2]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for initial equity grants to the Issuer's non-employee directors on the date of the Reporting Person's commencement of service to the Issuer.
  • [F3]The options shall vest in equal monthly installments over 36 months following July 14, 2022, subject to continued service to the Issuer by the Reporting Person.

Issuer

SpringWorks Therapeutics, Inc.

CIK 0001773427

Entity typeother

Related Parties

1
  • filerCIK 0001474632

Filing Metadata

Form type
4
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 6:07 AM ET
Size
7.8 KB